EGFR-425
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR-425, covering 2017-05-09 to 2017-05-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas [Phase 2]